Risk adaptive neoadjuvant surgery approach for head and neck cancer: lessons learned from the experience

.ical

09-12, 16:30–17:00 (Europe/Istanbul), Head & Neck Surgery 3

Trevor Hackman

Dr Hackman serves as a Distinguished Professor of Head and Neck Surgery at the University of North Carolina and Vice Chair of Inpatient Operations and Quality, as well as Chair of the Patient Care Section for the American Head and Neck Society, and member of the Executive Committee for the Salivary Gland Section of AHNS. He has over 15 years of experience with risk adaptive neoadjuvant therapy prior to surgery for mucosal head and neck cancer, and also pioneers the largest volume in-office sialendoscopy practice in the US.

This speaker also appears in:

• Office sialendoscopy
• Treatment options for sialolithiasis
• Personalized Approaches in Head and Neck Cancer: Biomarkers, Targeted Therapies, and Surgical Decision-Making

Sid Puram

This speaker also appears in:

• Neoadjuvant Immunotherapy in Head and Neck Cancer: Where we are and where we are going?